5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We examined the lifetime experience of hallucinations and delusions associated with transient methamphetamine-related psychosis (MAP), persistent MAP and primary psychosis among a cohort of dependent methamphetamine users. Participants were classified as having (a) no current psychotic symptoms, (n=110); (b) psychotic symptoms only when using methamphetamine (transient MAP, n=85); (c) psychotic symptoms both when using methamphetamine and when abstaining from methamphetamine (persistent MAP, n=37), or (d) meeting DSM-IV criteria for lifetime schizophrenia or mania (primary psychosis, n=52). Current psychotic symptoms were classified as a score of 4 or more on any of the Brief Psychiatric Rating Scale items of suspiciousness, hallucinations or unusual thought content in the past month. Lifetime psychotic diagnoses and symptoms were assessed using the Composite International Diagnostic Interview. Transient MAP was associated with persecutory delusions and tactile hallucinations (compared to the no symptom group). Persistent MAP was additionally associated with delusions of reference, thought interference and complex auditory, visual, olfactory and tactile hallucinations, while primary psychosis was also associated with delusions of thought projection, erotomania and passivity. The presence of non-persecutory delusions and hallucinations across various modalities is a marker for persistent MAP or primary psychosis in people who use methamphetamine.

          Related collections

          Author and article information

          Journal
          Psychiatry Res
          Psychiatry research
          Elsevier BV
          1872-7123
          0165-1781
          May 2017
          : 251
          Affiliations
          [1 ] National Drug Research Institute, Faculty of Health Sciences, Curtin University, Perth, Australia; Centre for Research on Ageing, Health and Well-being, the Australian National University, Canberra, Australia; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. Electronic address: rebecca.mcketin@curtin.edu.au.
          [2 ] School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.
          [3 ] School of Applied Psychology, Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.
          [4 ] Centre for Research on Ageing, Health and Well-being, the Australian National University, Canberra, Australia.
          [5 ] Turning Point, Eastern Health and Monash University, Melbourne, Australia.
          Article
          S0165-1781(16)31641-9
          10.1016/j.psychres.2017.02.028
          28282630
          88bf6e61-b12a-476e-ab17-4feb0f082c9a
          History

          Amphetamine,Amphetamine-related disorders,Central nervous system stimulants,Hallucinations,Paranoia,Psychotic disorders,Street drugs

          Comments

          Comment on this article